Can AI fix what's broken inside pharma — or is it too high-stakes and too guarded to let AI in? Jonathan Green talks with pharmaceutical expert Wendy Rockwell about the realities of bringing AI into one of the most regulated, security-conscious industries on earth: million-dollar legacy systems, painfully long buying cycles, and the trust problem when AI gives you two different answers to the same question. Key Takeaways: • Pharma is high-stakes — a wrong answer isn't an inconvenience, it's a risk • Legacy systems cost millions and fragment across regions, making AI adoption hard • AI's inconsistency (same question, different answers) is a real blocker in regulated work • The industry is extremely guarded — security and internet restrictions slow everything • Long buying cycles mean AI has to prove itself before it gets in the door Notable Quotes: "You can ask the same question twice and get two different answers." — Wendy Rockwell "We're really, really, really guarded." — Wendy Rockwell Connect with Wendy Rockwell: LinkedIn: https://www.linkedin.com/in/wendy-rockwellmba Enjoyed this? Follow The Artificial Intelligence Podcast and share it with someone in healthcare or pharma.Connect with Jonathan Green
- The Bestseller: ChatGPT Profits
- Free Gift: The Master Prompt for ChatGPT
- Free Book on Amazon: Fire Your Boss
- Podcast Website: https://artificialintelligencepod.com/
- Subscribe, Rate, and Review: https://artificialintelligencepod.com/itunes
- Video Episodes: https://www.youtube.com/@ArtificialIntelligencePodcast